Physician profile
David Chang
NPI 1457730269
$23,411.33
in general payments reported to CMS, 2019-2025
18 companies · $6,095 in 2025
The $6,095 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $1,892 · 2021: $844 · 2022: $4,034 · 2023: $8,623 · 2024: $1,708 · 2025: $6,095.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,007 · Food and Beverage: $5,289 · Consulting Fee: $1,950 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,875 · Grant: $1,000 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,007.32 |
| Food and Beverage | $5,288.57 |
| Consulting Fee | $1,950.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,875.00 |
| Grant | $1,000.00 |
| Education | $304.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,602.44 | 2021-2025 | Aveir, Accent, Gallant |
| Medtronic, INC. | $3,961.77 | 2021-2025 | Micra, Tyrx, Corevalve Evolut R |
| Boston Scientific Corporation | $2,565.15 | 2023-2025 | General - Ep, Watchman Flx, Watchman Access System |
| Biotronik INC. | $2,110.11 | 2020-2023 | Acticor 7 Vr-T Dx, Plexa Promri |
| Beone Medicines USA, INC. | $1,950.00 | 2025 | |
| Cook Incorporated | $932.15 | 2020 | |
| Biosense Webster, INC. | $896.80 | 2022-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Astrazeneca Pharmaceuticals Lp | $499.09 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $201.22 | 2020-2021 | |
| Pfizer INC. | $168.08 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $157.26 | 2023-2025 | Optimizer, Optimizer |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Cardiva Medical, INC. | $52.40 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Endotronix, INC. | $25.84 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.32 | 2022 | |
| Cordis US Corp. | $20.91 | 2024 | Mynx Venous Vcd |
| Novartis Pharmaceuticals Corporation | $20.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.